Evolus, Inc. (EOLS)
NASDAQ: EOLS · IEX Real-Time Price · USD
10.66
-0.42 (-3.79%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Evolus Market Cap
Evolus has a market cap or net worth of $667.43 million as of July 2, 2024. Its market cap has increased by 58.87% in one year.
Market Cap
667.43M
Enterprise Value
697.12M
1-Year Change
58.87%
Ranking
Category
Stock Price
$10.66
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $667.43M, an increase of 146.01%. That is a compound annual growth rate of 15.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 667.40M | 10.90% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 713.55M |
| Alumis | 706.88M |
| Praxis Precision Medicines | 704.67M |
| The Pennant Group | 703.07M |
| Embecta | 700.69M |
| Phibro Animal Health | 690.18M |
| InnovAge Holding | 685.38M |
| UroGen Pharma | 677.82M |